Publications from OUS - Dept. of Microbiology, Virology research group (Kaarbø)

204 publications found

Publications 2020

  1. Aulokken TM, Parkar AP, Markussen TV, Ashraf H, Mynarek GK, Nes H, Muller F, Schubert M, Jorgensen A, Blomberg SM, Bjornerheim R, Klow NE, Hopp E (2020)
    Imaging of patients with COVID-19
    Tidsskr. Nor. Laegeforen., 140 (8), 756-760
  2. Holter JC, Pischke SE, de Boer E, Lind A, Jenum S, Holten AR, Tonby K, Barratt-Due A, Sokolova M, Schjalm C, Chaban V, Kolderup A, Tran T, Tollefsrud Gjølberg T, Skeie LG, Hesstvedt L, Ormåsen V, Fevang B, Austad C, Müller KE, Fladeby C, Holberg-Petersen M, Halvorsen B, Müller F, Aukrust P et al. (2020)
    Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
    Proc Natl Acad Sci U S A, 117 (40), 25018-25025
    DOI 10.1073/pnas.2010540117, PubMed 32943538
  3. Lorentzen EM, Henriksen S, Kaur A, Kro GB, Hammarström C, Hirsch HH, Midtvedt K, Rinaldo CH (2020)
    Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor
    Virol J, 17 (1), 5
    DOI 10.1186/s12985-019-1275-9, PubMed 31924245
  4. Strand J, Gul KA, Erichsen HC, Lundman E, Berge MC, Trømborg AK, Sørgjerd LK, Ytre-Arne M, Hogner S, Halsne R, Gaup HJ, Osnes LT, Kro GAB, Sorte HS, Mørkrid L, Rowe AD, Tangeraas T, Jørgensen JV, Alme C, Bjørndalen TEH, Rønnestad AE, Lang AM, Rootwelt T, Buechner J, Øverland T et al. (2020)
    Second-Tier Next Generation Sequencing Integrated in Nationwide Newborn Screening Provides Rapid Molecular Diagnostics of Severe Combined Immunodeficiency
    Front Immunol, 11, 1417
    DOI 10.3389/fimmu.2020.01417, PubMed 32754152
  5. Taxt AM, Grødeland G, Lind A, Müller F (2020)
    Status of COVID-19 vaccine development
    Tidsskr Nor Laegeforen, 140 (13)
    DOI 10.4045/tidsskr.20.0676, PubMed 32998488
  6. Tollånes MC, Bakken Kran AM, Abildsnes E, Jenum PA, Breivik AC, Sandberg S (2020)
    Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2
    Clin Chem Lab Med, 58 (9), 1595-1600
    DOI 10.1515/cclm-2020-0628, PubMed 32598303
  7. Ueland T, Heggelund L, Lind A, Holten AR, Tonby K, Michelsen AE, Jenum S, Jørgensen MJ, Barratt-Due A, Skeie LG, Nordøy I, Aanensen Fraz MS, Quist-Paulsen E E, Pischke SE, Johal SK, Hesstvedt L, Bogen M, Fevang B, Halvorsen B, Müller F, Bekken GK, Mollnes TE, Dudman S, Aukrust P, Dyrhol-Riise AM et al. (2020)
    Elevated plasma sTIM-3 levels in patients with severe COVID-19
    J Allergy Clin Immunol (in press)
    DOI 10.1016/j.jaci.2020.09.007, PubMed 32971109
  8. Ulvestad E, Kommedal O, Simonsen GS, Muller F, Leegaard TM, Lohr IH, Nordbo SA (2020)
    Norway's microbiological outbreak preparedness is under threat
    Tidsskr. Nor. Laegeforen., 140 (11), 1096-1097

Publications 2019

  1. Bösl K, Ianevski A, Than TT, Andersen PI, Kuivanen S, Teppor M, Zusinaite E, Dumpis U, Vitkauskiene A, Cox RJ, Kallio-Kokko H, Bergqvist A, Tenson T, Merits A, Oksenych V, Bjørås M, Anthonsen MW, Shum D, Kaarbø M, Vapalahti O, Windisch MP, Superti-Furga G, Snijder B, Kainov D, Kandasamy RK (2019)
    Common Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis
    Front Immunol, 10, 2186
    DOI 10.3389/fimmu.2019.02186, PubMed 31636628
  2. Hesstvedt L, Gaustad P, Müller F, Torp Andersen C, Brunborg C, Mylvaganam H, Leiva RA, Berdal JE, Egil Ranheim T, Johnsen BO, Falch BM, Grimnes G, Skogen V, Haarr E, Sandmo Lyngøy A, Wik Larssen K, Hannula R, Åsheim Hansen B, Nordøy I, Norwegian Fungal Network (2019)
    The impact of age on risk assessment, therapeutic practice and outcome in candidemia
    Infect Dis (Lond), 51 (6), 425-434
    DOI 10.1080/23744235.2019.1595709, PubMed 31010380
  3. Olsen BC, Stubhaug TT, Berild JD (2019)
    A woman in her fifties with trismus and muscle spasms
    Tidsskr Nor Laegeforen, 139 (16)
    DOI 10.4045/tidsskr.18.0987, PubMed 31686491
  4. Paraskevis D, Beloukas A, Stasinos K, Pantazis N, de Mendoza C, Bannert N, Meyer L, Zangerle R, Gill J, Prins M, d'Arminio Montforte A, Kran AB, Porter K, Touloumi G, CASCADE collaboration of EuroCoord (2019)
    HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors
    BMC Med, 17 (1), 4
    DOI 10.1186/s12916-018-1241-1, PubMed 30616632
  5. Quist-Paulsen E, Kran AB, Lindland ES, Ellefsen K, Sandvik L, Dunlop O, Ormaasen V (2019)
    To what extent can clinical characteristics be used to distinguish encephalitis from encephalopathy of other causes? Results from a prospective observational study
    BMC Infect Dis, 19 (1), 80
    DOI 10.1186/s12879-018-3570-2, PubMed 30669985
  6. Quist-Paulsen E, Ormaasen V, Kran AB, Dunlop O, Ueland PM, Ueland T, Eikeland R, Aukrust P, Nordenmark TH (2019)
    Encephalitis and aseptic meningitis: short-term and long-term outcome, quality of life and neuropsychological functioning
    Sci Rep, 9 (1), 16158
    DOI 10.1038/s41598-019-52570-2, PubMed 31695095

Publications 2018

  1. Barlinn R, Dudman SG, Trogstad L, Gibory M, Muller F, Magnus P, Rollag H (2018)
    Maternal and congenital cytomegalovirus infections in a population-based pregnancy cohort study
    APMIS, 126 (12), 899-906
    DOI 10.1111/apm.12899, PubMed 30378168
  2. Knudsen PK, Gammelsrud KW, Alfsnes K, Steinbakk M, Abrahamsen TG, Müller F, Bohlin J (2018)
    Transfer of a bla CTX-M-1-carrying plasmid between different Escherichia coli strains within the human gut explored by whole genome sequencing analyses
    Sci Rep, 8 (1), 280
    DOI 10.1038/s41598-017-18659-2, PubMed 29321570
  3. Nordheim E, Olafsson Storrø M, Natvik AK, Birkeland Kro G, Midtvedt K, Varberg Reisaeter A, Hagness M, Fevang B, Pettersen FO (2018)
    Donor-derived strongyloidiasis after organ transplantation in Norway
    Transpl Infect Dis, 21 (1), e13008
    DOI 10.1111/tid.13008, PubMed 30295406
  4. Nordøy I, Hesstvedt L, Torp Andersen C, Mylvaganam H, Kols NI, Falch BM, Tofteland S, Müller F, Denning DW (2018)
    An Estimate of the Burden of Fungal Disease in Norway
    J Fungi (Basel), 4 (1)
    DOI 10.3390/jof4010029, PubMed 29466284
  5. Olson A, Bannert N, Sönnerborg A, de Mendoza C, Price M, Zangerle R, Chaix ML, Prins M, Kran AB, Gill J, Paraskevis D, Porter K, for CASCADE Collaboration in EuroCoord (2018)
    Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort
    AIDS, 32 (2), 161-169
    DOI 10.1097/QAD.0000000000001689, PubMed 29112061
  6. Quist-Paulsen E, Aukrust P, Kran AB, Dunlop O, Ormaasen V, Stiksrud B, Midttun Ø, Ueland T, Ueland PM, Mollnes TE, Dyrhol-Riise AM (2018)
    High neopterin and IP-10 levels in cerebrospinal fluid are associated with neurotoxic tryptophan metabolites in acute central nervous system infections
    J Neuroinflammation, 15 (1), 327
    DOI 10.1186/s12974-018-1366-3, PubMed 30470234
  7. Winje BA, White R, Syre H, Skutlaberg DH, Oftung F, Mengshoel AT, Blix HS, Brantsæter AB, Holter EK, Handal N, Simonsen GS, Afset JE, Bakken Kran AM (2018)
    Stratification by interferon-γ release assay level predicts risk of incident TB
    Thorax, 73 (7), 652-661
    DOI 10.1136/thoraxjnl-2017-211147, PubMed 29622693

Publications 2017

  1. Hole K, Størset E, Olastuen A, Haslemo T, Kro GB, Midtvedt K, Åsberg A, Molden E (2017)
    Recovery of CYP3A Phenotype after Kidney Transplantation
    Drug Metab Dispos, 45 (12), 1260-1265
    DOI 10.1124/dmd.117.078030, PubMed 28928137
  2. Knudsen PK, Brandtzaeg P, Høiby EA, Bohlin J, Samuelsen Ø, Steinbakk M, Abrahamsen TG, Müller F, Gammelsrud KW (2017)
    Impact of extensive antibiotic treatment on faecal carriage of antibiotic-resistant enterobacteria in children in a low resistance prevalence setting
    PLoS One, 12 (11), e0187618
    DOI 10.1371/journal.pone.0187618, PubMed 29112974
  3. Nguyen CB, Alsøe L, Lindvall JM, Sulheim D, Fagermoen E, Winger A, Kaarbø M, Nilsen H, Wyller VB (2017)
    Whole blood gene expression in adolescent chronic fatigue syndrome: an exploratory cross-sectional study suggesting altered B cell differentiation and survival
    J Transl Med, 15 (1), 102
    DOI 10.1186/s12967-017-1201-0, PubMed 28494812
  4. Sand MK, Stubhaug TT, Jørstad ØK (2017)
    [Atypical optic neuritis]
    Tidsskr Nor Laegeforen, 137 (10), 731
    DOI 10.4045/tidsskr.16.1063, PubMed 28551973
  5. Smeland TE, Müller F, Blomfeldt A, Stavem K, Aamot HV (2017)
    No associations established between single nucleotide polymorphisms in human Toll-like receptor 2 and Toll-interacting protein and Staphylococcus aureus bloodstream infections
    APMIS, 125 (10), 927-932
    DOI 10.1111/apm.12734, PubMed 28736863
  6. Stav-Noraas TE, Edelmann RJ, Poulsen LC, Sundnes O, Phung D, Küchler AM, Müller F, Kamen AA, Haraldsen G, Kaarbø M, Hol J (2017)
    Endothelial IL-33 Expression Is Augmented by Adenoviral Activation of the DNA Damage Machinery
    J Immunol, 198 (8), 3318-3325
    DOI 10.4049/jimmunol.1600054, PubMed 28258201

Publications 2016

  1. Blomfeldt A, Aamot HV, Eskesen AN, Müller F, Monecke S (2016)
    Correction for Blomfeldt et al., Molecular Characterization of Methicillin-Sensitive Staphylococcus aureus Isolates from Bacteremic Patients in a Norwegian University Hospital
    J Clin Microbiol, 54 (9), 2404
    DOI 10.1128/JCM.01436-16, PubMed 27578159
  2. Holter JC, Ueland T, Jenum PA, Müller F, Brunborg C, Frøland SS, Aukrust P, Husebye E, Heggelund L (2016)
    Risk Factors for Long-Term Mortality after Hospitalization for Community-Acquired Pneumonia: A 5-Year Prospective Follow-Up Study
    PLoS One, 11 (2), e0148741
    DOI 10.1371/journal.pone.0148741, PubMed 26849359
  3. Jørgensen SF, Reims HM, Frydenlund D, Holm K, Paulsen V, Michelsen AE, Jørgensen KK, Osnes LT, Bratlie J, Eide TJ, Dahl CP, Holter E, Tronstad RR, Hanevik K, Brattbakk HR, Kaveh F, Fiskerstrand T, Kran AB, Ueland T, Karlsen TH, Aukrust P, Lundin KE, Fevang B (2016)
    A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency
    Am J Gastroenterol, 111 (10), 1467-1475
    DOI 10.1038/ajg.2016.329, PubMed 27527747
  4. Rosenstierne MW, Karlberg H, Bragstad K, Lindegren G, Stoltz ML, Salata C, Kran AM, Dudman SG, Mirazimi A, Fomsgaard A (2016)
    Rapid Bedside Inactivation of Ebola Virus for Safe Nucleic Acid Tests
    J Clin Microbiol, 54 (10), 2521-9
    DOI 10.1128/JCM.00346-16, PubMed 27466385
  5. Siljan WW, Holter JC, Nymo SH, Schjalm C, Müller F, Jenum PA, Husebye E, Ueland T, Aukrust P, Mollnes TE, Heggelund L (2016)
    Circulating cell-free DNA is elevated in community-acquired bacterial pneumonia and predicts short-term outcome
    J Infect, 73 (4), 383-6
    DOI 10.1016/j.jinf.2016.07.011, PubMed 27452197
  6. Stubhaug TT, Reiakvam OM, Stensvold CR, Hermansen NO, Holberg-Petersen M, Antal EA, Gaustad K, Førde IS, Heger B (2016)
    Fatal primary amoebic meningoencephalitis in a Norwegian tourist returning from Thailand
    JMM Case Rep, 3 (3), e005042
    DOI 10.1099/jmmcr.0.005042, PubMed 28348761

Publications 2015

  1. Béziat V, Sleiman M, Goodridge JP, Kaarbø M, Liu LL, Rollag H, Ljunggren HG, Zimmer J, Malmberg KJ (2015)
    Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients
    Front Immunol, 6, 507
    DOI 10.3389/fimmu.2015.00507, PubMed 26500647
  2. Broch K, Andreassen AK, Hopp E, Leren TP, Scott H, Müller F, Aakhus S, Gullestad L (2015)
    Results of comprehensive diagnostic work-up in 'idiopathic' dilated cardiomyopathy
    Open Heart, 2 (1), e000271
    DOI 10.1136/openhrt-2015-000271, PubMed 26468400
  3. Holter JC, Müller F, Bjørang O, Samdal HH, Marthinsen JB, Jenum PA, Ueland T, Frøland SS, Aukrust P, Husebye E, Heggelund L (2015)
    Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway
    BMC Infect Dis, 15, 64
    DOI 10.1186/s12879-015-0803-5, PubMed 25887603
  4. Kaarbø M, Storm ML, Qu S, Wæhre H, Risberg B, Danielsen HE, Saatcioglu F (2015)
    Correction: TCTP is an androgen-regulated gene implicated in prostate cancer
    PLoS One, 10 (5), e0128727
    DOI 10.1371/journal.pone.0128727, PubMed 25973603
  5. Rollag H, Holter E, Muller F (2015)
    Hearing loss in children in Ostfold county 2000-09
    Tidsskr. Nor. Laegeforen., 135 (6), 511
  6. Rollag H, Holter E, Müller F (2015)
    [Re: Hearing loss in children in Östfold county 2000-09]
    Tidsskr Nor Laegeforen, 135 (6), 513
    DOI 10.4045/tidsskr.15.0262, PubMed 25806741
  7. Raastad R, Tvete IF, Abrahamsen TG, Berild D, Leegaard TM, Walberg M, Müller F (2015)
    A worrying trend in weight-adjusted paediatric antibiotic use in a Norwegian tertiary care hospital
    Acta Paediatr, 104 (7), 687-92
    DOI 10.1111/apa.12994, PubMed 25753620

Publications 2014

  1. Brigtsen AK, Dedi L, Melby KK, Holberg-Petersen M, Radtke A, Lyng RV, Andresen LL, Jacobsen AF, Fugelseth D, Whitelaw A (2014)
    Comparison of PCR and serotyping of Group B Streptococcus in pregnant women: the Oslo GBS-study
    J Microbiol Methods, 108, 31-5
    DOI 10.1016/j.mimet.2014.11.001, PubMed 25447890
  2. Fossum Moen AE, Holberg-Petersen M, Andresen LL, Blomfeldt A (2014)
    spa typing alone is not sufficient to demonstrate endemic establishment of meticillin-resistant Staphylococcus aureus in a low-prevalence country
    J Hosp Infect, 88 (2), 72-7
    DOI 10.1016/j.jhin.2014.06.008, PubMed 25085462
  3. Kran AM (2014)
    [Local food at exotic vacation]
    Tidsskr Nor Laegeforen, 134 (2), 192-3
    DOI 10.4045/tidsskr.13.1372, PubMed 24477156
  4. Sulheim D, Fagermoen E, Winger A, Andersen AM, Godang K, Müller F, Rowe PC, Saul JP, Skovlund E, Øie MG, Wyller VB (2014)
    Disease mechanisms and clonidine treatment in adolescent chronic fatigue syndrome: a combined cross-sectional and randomized clinical trial
    JAMA Pediatr, 168 (4), 351-60
    DOI 10.1001/jamapediatrics.2013.4647, PubMed 24493300

Publications 2013

  1. Kaarbø M, Crane DI, Murrell WG (2013)
    RhoA regulation of cardiomyocyte differentiation
    ScientificWorldJournal, 2013, 491546
    DOI 10.1155/2013/491546, PubMed 23935420

Publications 2012

  1. Ranneberg-Nilsen T, Rollag H, Slettebakk R, Backe PH, Olsen Ø, Luna L, Bjørås M (2012)
    The chromatin remodeling factor SMARCB1 forms a complex with human cytomegalovirus proteins UL114 and UL44
    PLoS One, 7 (3), e34119
    DOI 10.1371/journal.pone.0034119, PubMed 22479537

Publications 2010

  1. Asberg A, Jardine AG, Bignamini AA, Rollag H, Pescovitz MD, Gahlemann CC, Humar A, Hartmann A, VICTOR Study Group (2010)
    Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients
    Am J Transplant, 10 (8), 1881-8
    DOI 10.1111/j.1600-6143.2010.03114.x, PubMed 20486914
  2. Holberg-Petersen M, Jenum PA, Mannsåker T, Melby KK (2010)
    Comparison of PCR with culture applied on nasopharyngeal and throat swab specimens for the detection of Bordetella pertussis
    Scand J Infect Dis, 43 (3), 221-4
    DOI 10.3109/00365548.2010.538855, PubMed 21108541

Publications 2009

  1. Kran AM, Jonassen TØ, Sannes M, Jakobsen K, Lind A, Maeland A, Holberg-Petersen M (2009)
    Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes
    J Clin Microbiol, 47 (7), 2170-4
    DOI 10.1128/JCM.00519-09, PubMed 19420166

Publications 2008

  1. Ranneberg-Nilsen T, Dale HA, Luna L, Slettebakk R, Sundheim O, Rollag H, Bjørås M (2008)
    Characterization of human cytomegalovirus uracil DNA glycosylase (UL114) and its interaction with polymerase processivity factor (UL44)
    J Mol Biol, 381 (2), 276-88
    DOI 10.1016/j.jmb.2008.05.028, PubMed 18599070

Publications 2006

  1. Ranneberg-Nilsen T, Bjørås M, Luna L, Slettebakk R, Dale HA, Seeberg E, Rollag H (2006)
    Human cytomegalovirus infection modulates DNA base excision repair in fibroblast cells
    Virology, 348 (2), 389-97
    DOI 10.1016/j.virol.2006.01.001, PubMed 16476462

Publications 2005

  1. Hjelmesaeth J, Müller F, Jenssen T, Rollag H, Sagedal S, Hartmann A (2005)
    Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage
    Nephrol Dial Transplant, 20 (11), 2311-5
    DOI 10.1093/ndt/gfi033, PubMed 16046502

Publications 2002

  1. Degré M (2002)
    Has cytomegalovirus infection any role in the development of atherosclerosis?
    Clin Microbiol Infect, 8 (4), 191-5
    DOI 10.1046/j.1469-0691.2002.00407.x, PubMed 12047409
  2. Degre M (2002)
    Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?
    Vox Sang., 83 (1), 87
  3. Engelfriet CP, Reesink HW, Hernandez JM, Sauleda S, O'Riordan J, Prati D, Mozzi F, Lin CK, Cuypers HT, Vranckx R, Yoshizawa H, Tomono T, Flanagan P, Sabino EC, Politis C, Tegtmeier GE, Carasa MAV, Hewlett IK, Yu MYW, Epstein JS, Eglin R, Barbara J, Coste J, Cornillot C, Hyland CA et al. (2002)
    Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
    Vox Sang., 82 (2), 87-111
  4. Eskild A, Jeansson S, Stray-Pedersen B, Jenum PA (2002)
    Herpes simplex virus type-2 infection in pregnancy: no risk of fetal death: results from a nested case-control study within 35,940 women
    BJOG, 109 (9), PII S1470-0328(02)01934-1-1035

Publications 2001

  1. Degré M, Kristiansen KI, Rollag H, Holter E, Nordal KP (2001)
    Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients
    Clin Microbiol Infect, 7 (5), 254-60
    DOI 10.1046/j.1198-743x.2001.00251.x, PubMed 11422252
  2. Degré M, Ranneberg-Nilsen T, Beck S, Rollag H, Fiane AE (2001)
    Human cytomegalovirus productively infects porcine endothelial cells in vitro
    Transplantation, 72 (7), 1334-7
    DOI 10.1097/00007890-200110150-00028, PubMed 11602867
  3. Jeansson S, Kvien TK (2001)
    Acanthamoeba polyphaga in rheumatoid arthritis: possibility for a chronic infection
    Scand J Immunol, 53 (6), 610-4
    DOI 10.1046/j.1365-3083.2001.00926.x, PubMed 11422910

Publications 2000

  1. Degré M (2000)
    [Poliomyelitis--a step closer to eradication]
    Tidsskr Nor Laegeforen, 120 (15), 1718
    PubMed 10904653

Publications 1999

  1. Grabowska A, Jameson C, Laing P, Jeansson S, Sj Gren-Jansson E, Taylor J, Cunningham A, Irving WL (1999)
    Identification of type-specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by the majority of patients infected with HSV-2, but not by those infected with HSV-1
    J Gen Virol, 80 ( Pt 7), 1789-1798
    DOI 10.1099/0022-1317-80-7-1789, PubMed 10423148
  2. Holberg-Petersen M, Steinbakk M, Figenschau KJ, Jantzen E, Eng J, Melby KK (1999)
    Identification of clinical isolates of Mycobacterium spp. by sequence analysis of the 16S ribosomal RNA gene. Experience from a clinical laboratory
    APMIS, 107 (2), 231-9
    DOI 10.1111/j.1699-0463.1999.tb01549.x, PubMed 10225322

Publications 1998

  1. Flugsrud LB, Degré M (1998)
    [Poliomyelitis--the beginning of the end]
    Tidsskr Nor Laegeforen, 118 (13), 1997-8
    PubMed 9656781

Publications 1997

  1. Holberg-Petersen M, Høgåsen AK, Høgåsen K, Abrahamsen TG, Degré M, Rollag H (1997)
    Infection with human cytomegalovirus (HCMV) stimulates monocyte production of complement factor 3
    Arch Virol, 142 (4), 689-98
    DOI 10.1007/s007050050111, PubMed 9170497
  2. Holberg-Petersen M, Rollag H, Beck S, Degré M (1997)
    The effect of human cytomegalovirus on selected functions of peripheral blood monocytes
    APMIS, 105 (2), 89-98
    DOI 10.1111/j.1699-0463.1997.tb00546.x, PubMed 9113070

Publications 1996

  1. Degré M (1996)
    Interferons and other cytokines in bacterial infections
    J Interferon Cytokine Res, 16 (6), 417-26
    DOI 10.1089/jir.1996.16.417, PubMed 8807494
  2. Degré M (1996)
    Cytokines and bacterial infections
    Biotherapy, 8 (3-4), 219-28
    DOI 10.1007/BF01877208, PubMed 8813334
  3. Holberg-Petersen M, Bukholm G, Haarr L, Langeland N, Degré M (1996)
    Human interferon reduces surface expression but not total production of herpes simplex virus type 1 glycoproteins gC and gE in heterologous hamster cells
    J Interferon Cytokine Res, 16 (9), 717-24
    DOI 10.1089/jir.1996.16.717, PubMed 8887056

Publications 1995

  1. Degré M (1995)
    [Infectious diseases--new and old, in new forms]
    Tidsskr Nor Laegeforen, 115 (23), 2875-6
    PubMed 7570504
  2. Degré M (1995)
    [Transmissible spongiform encephalopathies--an unconventional contagious agent]
    Tidsskr Nor Laegeforen, 115 (25), 3137-40
    PubMed 8539696
  3. Degré M, Bukholm G (1995)
    Orally administered interferon-gamma but not tumor necrosis factor-alpha suppress infection with Salmonella typhimurium in a mouse model
    J Biol Regul Homeost Agents, 9 (1), 15-20
    PubMed 8553903

Publications 1994

  1. Degré M, Beck S (1994)
    Anti-HIV activity of dideoxynucleosides, foscarnet and fusidic acid is potentiated by human leukocyte interferon in blood-derived macrophages
    Chemotherapy, 40 (3), 201-8
    DOI 10.1159/000239193, PubMed 7515781
  2. Degré M, Bukholm G, Holter E, Müller F, Rollag H (1994)
    Rapid detection of cytomegalovirus infection in immunocompromised patients
    Eur J Clin Microbiol Infect Dis, 13 (8), 668-70
    DOI 10.1007/BF01973997, PubMed 7813501
  3. Holberg-Petersen M, Bukholm G, Rollag H, Degré M (1994)
    Infection with human cytomegalovirus enhances bacterial adhesiveness and invasiveness in permissive and semipermissive cells
    APMIS, 102 (9), 703-10
    DOI 10.1111/j.1699-0463.1994.tb05223.x, PubMed 7946274
  4. TIGALONOVA M, BJERKE JR, GALLATI H, DEGRE M, JABLONSKA S, MAJEWSKI S, MATRE R (1994)
    SERUM LEVELS OF INTERFERONS AND TNF-ALPHA ARE NOT CORRELATED TO PSORIASIS ACTIVITY AND THERAPY
    Acta Derm.-Venereol., 74 186, 25-27

Publications 1992

  1. Degré M (1992)
    [Prevention and treatment of influenza]
    Tidsskr Nor Laegeforen, 112 (16), 2052
    PubMed 1523619
  2. Degré M, Beck S, Rollag H (1992)
    Interferon-gamma may enhance infection of blood-derived macrophages with HIV-1 in the presence of HIV-positive serum
    APMIS, 100 (5), 465-9
    DOI 10.1111/j.1699-0463.1992.tb00898.x, PubMed 1586484

Publications 1991

  1. Degré M (1991)
    [Virologic rapid diagnosis]
    Tidsskr Nor Laegeforen, 111 (15), 1866
    PubMed 1853322
  2. Degré M (1991)
    [Antiviral agents for the systemic treatment of herpesvirus infections]
    Tidsskr Nor Laegeforen, 111 (21), 2663-4
    PubMed 1658971
  3. Degré M, Rollag H, Holter E, Tønjum T, Krajci Z, Bukholm G (1991)
    [Diagnosis of cytomegalovirus infections in hospitalized patients]
    Tidsskr Nor Laegeforen, 111 (28), 3401-4
    PubMed 1665258

Publications 1990

  1. Degré M (1990)
    [Latent and activated viral infections]
    Tidsskr Nor Laegeforen, 110 (21), 2747-8
    PubMed 2219044
  2. Degré M, Bukholm G (1990)
    Effect of tumor necrosis factor-alpha on infection with Salmonella typhimurium in a mouse model
    J Biol Regul Homeost Agents, 4 (4), 157-61
    PubMed 2128989

Publications 1989

  1. Degré M, Bukholm G, Czarniecki CW (1989)
    In vitro treatment of HEp-2 cells with human tumor necrosis factor-alpha and human interferons reduces invasiveness of Salmonella typhimurium
    J Biol Regul Homeost Agents, 3 (1), 1-7
    PubMed 2472042

Publications 1988

  1. Bukholm G, Degré M (1988)
    Shiga toxin inhibits the anti-invasive effect of interferons
    J Infect Dis, 157 (4), 849-50
    DOI 10.1093/infdis/157.4.849, PubMed 2450154
  2. Degré M, Bukholm G (1988)
    Effects of interferon and tumour necrosis factor on development of intracellular bacterial infections
    Acta Microbiol Hung, 35 (4), 405-10
    PubMed 2469282

Publications 1987

  1. Austgulen R, Nissen-Meyer J, Degré M, Espevik T (1987)
    Monocyte-derived influence on growth of normal human fibroblasts. The contribution of tumour necrosis factor to growth inhibition
    Scand J Immunol, 26 (2), 175-85
    DOI 10.1111/j.1365-3083.1987.tb02249.x, PubMed 3114873

Publications 1986

  1. Bruserud O, Degré M, Thorsby E (1986)
    Interleukin 2- and interferon-production and expression of interleukin 2 receptors by human mononuclear cells stimulated with mumps virus or phytohaemagglutinin
    Acta Pathol Microbiol Immunol Scand C, 94 (2), 51-5
    DOI 10.1111/j.1699-0463.1986.tb02089.x, PubMed 3090859
  2. Bukholm G, Modalsli K, Degré M (1986)
    Effect of measles-virus infection and interferon treatment on invasiveness of Shigella flexneri in HEp2-cell cultures
    J Med Microbiol, 22 (4), 335-41
    DOI 10.1099/00222615-22-4-335, PubMed 3098977
  3. DEGRE M (1986)
    INTERACTION BETWEEN VIRAL AND BACTERIAL-INFECTIONS IN THE RESPIRATORY-TRACT
    Scand. J. Infect. Dis. (49), 140-145
  4. Degré M (1986)
    Interaction between viral and bacterial infections in the respiratory tract
    Scand J Infect Dis Suppl, 49, 140-5
    PubMed 2434989
  5. Degré M, Holberg-Petersen M (1986)
    Influence of a carcinogenic agent, 7.12 dimethylbenz (alpha) anthracene (DMBA), on production of interferon alpha/beta in murine and human cells
    Acta Pathol Microbiol Immunol Scand B, 94 (1), 51-5
    DOI 10.1111/j.1699-0463.1986.tb03019.x, PubMed 3014815
  6. Jonassen TO, Grinde B (1986)
    Proteolytic response to nutritional step-down in Tetrahymena
    Exp Cell Res, 163 (1), 165-74
    DOI 10.1016/0014-4827(86)90569-0, PubMed 3510885
  7. Livden JK, Bjerke JR, Degre M, Matre R (1986)
    The effect of Goeckerman therapy on interferon in serum and suction blister fluid from patients with psoriasis
    Br J Dermatol, 114 (2), 217-25
    DOI 10.1111/j.1365-2133.1986.tb02800.x, PubMed 2418865
  8. Mustafa AS, Kvalheim G, Degre M, Godal T (1986)
    Mycobacterium bovis BCG-induced human T-cell clones from BCG-vaccinated healthy subjects: antigen specificity and lymphokine production
    Infect Immun, 53 (3), 491-7
    DOI 10.1128/IAI.53.3.491-497.1986, PubMed 2427449
  9. Siebke JC, von der Lippe B, Hansson BG, Nordenfelt E, Degré M (1986)
    Prevalence and clinical effects of delta agent. Infections in Norwegian population subgroups
    Scand J Infect Dis, 18 (1), 33-6
    DOI 10.3109/00365548609032303, PubMed 3961420
  10. von der Lippe E, Frøland S, Rollag H, Degre M (1986)
    Effect of fibroblast interferon and recombinant gamma interferon on zymosan-induced nitroblue tetrazolium reduction in mouse peritoneal macrophages
    Acta Pathol Microbiol Immunol Scand B, 94 (5), 343-6
    DOI 10.1111/j.1699-0463.1986.tb03064.x, PubMed 3098042

Publications 1985

  1. BREDE HD, EHRENGUT W, PLOTKIN SA, SPIESS H, SCHILD G, GERSHON AA, DEGRE M, MENSER M, THIRY L, EGGERS HJ, SIMON C, PREBLUD SR, AMBROSCH F, MORRONDO RN, NICHOLSON K, BOUGHTON CR, DUDGEON JA, ENDERS G (1985)
    THE NEED FOR IMMUNIZATION AGAINST VARICELLA - GENERAL DISCUSSION
    Postgrad. Med. J., 61 4, 31-34
  2. Bukholm G, Degré M (1985)
    Effect of human gamma interferon on invasiveness of Salmonella typhimurium in HEp-2 cell cultures
    J Interferon Res, 5 (1), 45-53
    DOI 10.1089/jir.1985.5.45, PubMed 3921632
  3. Bukholm G, Holberg-Petersen M, Degré M (1985)
    Invasiveness of Salmonella typhimurium in HEp-2 cell cultures pretreated with UV-inactivated coxsackie virus
    Acta Pathol Microbiol Immunol Scand B, 93 (1), 61-5
    DOI 10.1111/j.1699-0463.1985.tb02852.x, PubMed 2984878
  4. Kjeldsberg E, Rollag H, Lund H, Holberg-Pettersen M, Degré M (1985)
    Effect of gamma interferon on spreading of mouse peritoneal macrophages on solid surfaces
    Acta Pathol Microbiol Immunol Scand B, 93 (3), 165-70
    DOI 10.1111/j.1699-0463.1985.tb02871.x, PubMed 3929557
  5. Qvigstad E, Onsrud M, Degré M, Skaug K (1985)
    Cell-mediated and humoral immune responses to chlamydial and herpesvirus antigens in patients with cervical carcinoma
    Gynecol Oncol, 20 (2), 184-9
    DOI 10.1016/0090-8258(85)90140-4, PubMed 2982703
  6. Slørdahl SH, Wiger D, Strømøy T, Degre M, Thørsby E, Lie SO (1985)
    Vaccination of children with malignant disease against varicella
    Postgrad Med J, 61 Suppl 4, 85-92
    PubMed 3014484

Publications 1984

  1. BJERKE JR, DEGRE M, HAUKENES G, KROGH HK, LIVDEN JK, MATRE R (1984)
    T-CELLS, INTERFERONS AND RETROVIRUS-LIKE PARTICLES IN PSORIATIC LESIONS
    Acta Derm.-Venereol. (113), 29-33
  2. BJERKE JR, HAUKENES G, LIVDEN JK, MATRE R, DEGRE M (1984)
    ACID-LABILE ALPHA-INTERFERON
    N. Engl. J. Med., 310 (14), 922-923
  3. Bukholm G, Berdal BP, Haug C, Degré M (1984)
    Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice
    Infect Immun, 45 (1), 62-6
    DOI 10.1128/IAI.45.1.62-66.1984, PubMed 6376362
  4. Bukholm G, Degré M (1984)
    Invasiveness of Salmonella typhimurium in HEp-2 cell cultures preinfected with Coxsackie B 1 virus
    Acta Pathol Microbiol Immunol Scand B, 92 (1), 45-51
    DOI 10.1111/j.1699-0463.1984.tb02792.x, PubMed 6324532
  5. Degré M (1984)
    [Interferon--recent developments at basic and application levels]
    Nord Med, 99 (3), 76-7, 71
    PubMed 6203095
  6. Degré M, Siebke JC, Frøland SS (1984)
    [Prevention of hepatitis B by vaccination]
    Tidsskr Nor Laegeforen, 104 (27), 1906-7
    PubMed 6515608
  7. Rollag H, Degré M, Sonnenfeld G (1984)
    Effects of interferon-alpha/beta and interferon-gamma preparations on phagocytosis by mouse peritoneal macrophages
    Scand J Immunol, 20 (2), 149-55
    DOI 10.1111/j.1365-3083.1984.tb00988.x, PubMed 6236548
  8. Siebke JC, Degré M (1984)
    Prevalence of viral hepatitis in the staff in Norwegian anaesthesiology units
    Acta Anaesthesiol Scand, 28 (5), 549-53
    DOI 10.1111/j.1399-6576.1984.tb02117.x, PubMed 6496015
  9. Slørdahl SH, Lie SO, Wiger D, Winsnes R, Degre M, Strømøy T, Thorsby E (1984)
    [Vaccination of immunosuppressed children against varicella]
    Tidsskr Nor Laegeforen, 104 (30), 2086-9
    PubMed 6095484
  10. Vinje O, Førre O, Degre M, Møller P (1984)
    Natural killer (NK) cell activity of peripheral blood lymphocytes from patients with Bechterew's syndrome (ankylosing spondylitis)
    Scand J Rheumatol, 13 (4), 297-302
    DOI 10.3109/03009748409111299, PubMed 6441246

Publications 1983

  1. BJERKE JR, HAUKENES G, LIVDEN JK, MATRE R, DEGRE M (1983)
    ACTIVATED LYMPHOCYTES-T, INTERFERON, AND RETROVIRUS-LIKE PARTICLES IN PSORIATIC LESIONS
    Arch. Dermatol., 119 (12), 955-956
  2. Bjerke JR, Haukenes G, Livden JK, Matre R, Degré M (1983)
    Activated T lymphocytes, interferon, and retrovirus-like particles in psoriatic lesions
    Arch Dermatol, 119 (12), 955-6
    PubMed 6197033
  3. Bjerke JR, Livden JK, Degré M, Matre R (1983)
    Interferon in suction blister fluid from psoriatic lesions
    Br J Dermatol, 108 (3), 295-9
    DOI 10.1111/j.1365-2133.1983.tb03967.x, PubMed 6187354
  4. Bukholm G, Degré M (1983)
    Effect of human leukocyte interferon on invasiveness of Salmonella species in HEp-2 cell cultures
    Infect Immun, 42 (3), 1198-202
    DOI 10.1128/IAI.42.3.1198-1202.1983, PubMed 6358041
  5. Degré M (1983)
    [Immunological defense factors against viral infections]
    Tidsskr Nor Laegeforen, 103 (3), 177-8
    PubMed 6845309
  6. Degré M (1983)
    [Vaccines against cytomegalovirus infection]
    Tidsskr Nor Laegeforen, 103 (3), 236-7
    PubMed 6302943
  7. Degré M, Belsnes K, Rollag H, Beck S, Sonnenfeld G (1983)
    Influence of the genotype of mice on the effect of interferon on phagocytic activity of macrophages
    Proc Soc Exp Biol Med, 173 (1), 27-31
    DOI 10.3181/00379727-173-41604, PubMed 6344094
  8. Degré M, Glasgow LA (1983)
    Establishment and preliminary characterization of a cell line persistently infected with Newcastle disease virus
    Acta Pathol Microbiol Immunol Scand B, 91 (6), 389-94
    DOI 10.1111/j.1699-0463.1983.tb00065.x, PubMed 6324529
  9. DeGré M, Mellbye OJ, Clarke-Jenssen O (1983)
    Immune interferon in serum and synovial fluid in rheumatoid arthritis and related disorders
    Ann Rheum Dis, 42 (6), 672-6
    DOI 10.1136/ard.42.6.672, PubMed 6418086
  10. Ritland S, Blomhoff JP, Degre M (1983)
    [Hepatitis B virus--hepatocellular carcinoma]
    Tidsskr Nor Laegeforen, 103 (33), 2237-9
    PubMed 6318382

Publications 1982

  1. DEGRE M (1982)
    BACTERIAL-MENINGITIS AFTER INFLUENZA
    Lancet, 1 (8275), 804
  2. Degré M, Rollag H (1982)
    Effect of murine beta-interferon preparation on phagocytosis and cyclic AMP levels in mouse peritoneal macrophages
    J Interferon Res, 2 (2), 151-7
    DOI 10.1089/jir.1982.2.151, PubMed 6288813
  3. Degré M, Rollag H, Kjeldsberg E (1982)
    Morphological parameters of the effect of interferon on mouse peritoneal macrophages
    Philos Trans R Soc Lond B Biol Sci, 299 (1094), 131-3
    DOI 10.1098/rstb.1982.0115, PubMed 6128749
  4. Dobloug JH, Førre O, Kvien TK, Egeland T, Degré M (1982)
    Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis
    Ann Rheum Dis, 41 (5), 490-4
    DOI 10.1136/ard.41.5.490, PubMed 6181746
  5. Lingaas E, Degré M (1982)
    [Screening for rubella antibodies in newly employed women at the National Hospital]
    Tidsskr Nor Laegeforen, 102 (25), 1272-3
    PubMed 7164071
  6. Melby K, Midtvedt T, Degré M (1982)
    Effect of human leukocyte interferon on phagocytic activity of polymorphonuclear leukocytes
    Acta Pathol Microbiol Immunol Scand B, 90 (3), 181-4
    DOI 10.1111/j.1699-0463.1982.tb00102.x, PubMed 6181651
  7. Rollag H, Degré M (1982)
    Effect of beta-interferon on in vitro spreading of mouse peritoneal macrophages
    Acta Pathol Microbiol Immunol Scand B, 90 (6), 389-95
    DOI 10.1111/j.1699-0463.1982.tb00136.x, PubMed 7168315
  8. Rollag H, Mørland B, Degré M (1982)
    Effect of a homologous beta-interferon preparation on degradation of Escherichia coli and on lysosomal enzyme activities in mouse peritoneal macrophages
    Acta Pathol Microbiol Immunol Scand B, 90 (2), 113-8
    DOI 10.1111/j.1699-0463.1982.tb00091.x, PubMed 6177190
  9. Siebke JC, Degré M, Ritland S, Enger SC (1982)
    Prevalence of hepatitis A antibodies in a normal population and some selected groups of patients in Norway
    Am J Epidemiol, 115 (2), 185-91
    DOI 10.1093/oxfordjournals.aje.a113290, PubMed 7058777

Publications 1981

  1. Degre M, Glasgow LA (1981)
    Effect of interferon on cyclic adenosine monophosphate levels in cells
    Antiviral Res, 1 (3), 185-92
    DOI 10.1016/0166-3542(81)90007-3, PubMed 6175278
  2. Degré M, Rollag H (1981)
    On the possible role of interferon in infections with non-viral agents
    Tex Rep Biol Med, 41, 388-94
    PubMed 6184830
  3. Degré M, Sonnenfeld G, Rollag H, Mørland B (1981)
    Effect of gamma interferon preparations on in vitro phagocytosis and degradation of Escherichia coli by mouse peritoneal macrophages
    J Interferon Res, 1 (4), 505-12
    DOI 10.1089/jir.1981.1.505, PubMed 6180084
  4. Egge K, Djupesland G, Modalsli B, Degré M (1981)
    Severe hearing loss and retinopathy in children: on the possible association with rubella virus infection
    Scand Audiol, 10 (2), 75-9
    DOI 10.3109/01050398109076165, PubMed 7280544
  5. Olstad R, Degré M, Seljelid R (1981)
    Production of immune interferon (type II) in cocultures of mouse peritoneal macrophages and syngeneic tumour cells
    Scand J Immunol, 13 (6), 605-8
    DOI 10.1111/j.1365-3083.1981.tb00175.x, PubMed 6171873
  6. Rollag H, Degré M (1981)
    Effect of interferon preparations on the uptake of non-opsonized Escherichia coli by mouse peritoneal macrophages
    Acta Pathol Microbiol Scand B, 89 (3), 153-9
    DOI 10.1111/j.1699-0463.1981.tb00169_89b.x, PubMed 6171991

Publications 1980

  1. Degré M (1980)
    Adsorption of interferon to homologous and heterologous cells. Brief report
    Arch Virol, 65 (1), 71-6
    DOI 10.1007/BF01340543, PubMed 6158931
  2. Degré M (1980)
    Antiviral and cell multiplication inhibitory activities of mouse interferon poreparations tested on an interferon sensitive murine sarcoma cell line
    Acta Pathol Microbiol Scand B, 88 (4), 219-23
    DOI 10.1111/j.1699-0463.1980.tb02631.x, PubMed 6158254
  3. Degré M, Rollag H (1980)
    Pathogenesis of Sendasi virus infection in mice. On the possible role of interferon on the development of disease
    Acta Pathol Microbiol Scand B, 88 (3), 177-81
    PubMed 6160724

Publications 1979

  1. Degré M, Rollag H (1979)
    Influence of interferon on the in vivo phagocytic activity of reticuloendothelial system cells
    J Reticuloendothel Soc, 25 (5), 489-93
    PubMed 458780
  2. Degré M, Rollag H (1979)
    Rubella screening by hemolysis-in-gel-test
    Lancet, 2 (8143), 644-5
    PubMed 90314
  3. Degré M, Rollag H (1979)
    Screening for rubella antibodies by a single radial haemolysis test
    NIPH Ann, 2 (2), 25-30
    PubMed 398458
  4. Djupesland G, Flottorp G, Degré M, Stien R, Skrede S (1979)
    Cochlear hearing loss and viral infection
    Acta Otolaryngol, 87 (3-4), 247-54
    DOI 10.3109/00016487909126416, PubMed 375666

Publications 1978

  1. Degré M (1978)
    Cholera toxin inhibits antiviral and growth inhibitory activities of human interferon
    Proc Soc Exp Biol Med, 157 (2), 253-5
    PubMed 202975
  2. Degré M (1978)
    Effect of human leukocyte interferon on the permeability of the cytoplasma membrane of cultured cells
    Acta Pathol Microbiol Scand B, 86B (5), 303-7
    DOI 10.1111/j.1699-0463.1978.tb00048.x, PubMed 716922
  3. Degré M, Bukholm G, Lund EE, Djupesland G (1978)
    Attempts to isolate virus from human trigeminal and facial ganglions
    Med Microbiol Immunol, 166 (1-4), 151-6
    DOI 10.1007/BF02121144, PubMed 214678
  4. Degré M, Wilhelmsen KW (1978)
    [Interferons. Biological principal and practical application]
    Tidsskr Nor Laegeforen, 98 (24), 1152-4
    PubMed 684722

Publications 1977

  1. Degré M, Gláz ET (1977)
    Interferon induction in human cell cultures by small molecular inducers (tilorone and acridines)
    Acta Pathol Microbiol Scand B, 85 (3), 189-94
    DOI 10.1111/j.1699-0463.1977.tb01695.x, PubMed 888701
  2. Degré M, Hovig B, Midtvedt T (1977)
    [Can the transport agar method be used for determination of resistance in urinary tract infections?]
    Tidsskr Nor Laegeforen, 97 (5), 248-50
    PubMed 841561
  3. Djupesland G, Degré M, Stien R, Skrede S (1977)
    Acute peripheral facial palsy. Part of a cranial polyneuropathy?
    Arch Otolaryngol, 103 (11), 641-4
    DOI 10.1001/archotol.1977.00780280041004, PubMed 200210

Publications 1976

  1. Dahl H, Degré M (1976)
    Human interferon and cell growth inhibition. I. Inhibitory effect of human interferon on the growth rate of cultured human cells
    Acta Pathol Microbiol Scand B, 84B (5), 285-92
    DOI 10.1111/j.1699-0463.1976.tb01939.x, PubMed 184682
  2. Dahl H, Degré M (1976)
    The effect of ascorbic acid on production of human interferon and the antiviral activity in vitro
    Acta Pathol Microbiol Scand B, 84B (5), 280-4
    DOI 10.1111/j.1699-0463.1976.tb01938.x, PubMed 970135
  3. DAHL H, DEGRE M (1976)
    EFFECT OF ASCORBIC-ACID ON PRODUCTION OF HUMAN INTERFERON AND ANTIVIRAL ACTIVITY INVITRO
    ACTA PATH MICRO IM B, 84 (5), 280-284
  4. Degré M, Dahl H, Vandvik B (1976)
    Interferon in the serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders
    Acta Neurol Scand, 53 (2), 152-60
    DOI 10.1111/j.1600-0404.1976.tb04333.x, PubMed 1266564
  5. Degré M, Hovig T (1976)
    Functional and ultrastructural studies of the effects of human interferon on cell membranes of in vitro cultured cells
    Acta Pathol Microbiol Scand B, 84B (6), 347-58
    DOI 10.1111/j.1699-0463.1976.tb01952.x, PubMed 187008
  6. Degre M, Vandvik B (1976)
    [Nobel prizes 1976 in physiology and medicine]
    Tidsskr Nor Laegeforen, 92 (33), 1754-5
    PubMed 996844
  7. Djupesland G, Berdal P, Johannessen TA, Degré M, Stien R, Skrede S (1976)
    Viral infection as a cause of acute peripheral facial palsy
    Arch Otolaryngol, 102 (7), 403-6
    DOI 10.1001/archotol.1976.00780120051005, PubMed 938319
  8. Rollag H, degré M (1976)
    Effect of antibiotics on interferon production in mice
    Acta Pathol Microbiol Scand B, 84B (6), 369-72
    DOI 10.1111/j.1699-0463.1976.tb01954.x, PubMed 998256
  9. Vandvik B, Norrby E, Nordal HJ, Degré M (1976)
    Oligoclonal measles virus-specific IgG antibodies isolated from cerebrospinal fluids, brain extracts, and sera from patients with subacute sclerosing panencephalitis and multiple sclerosis
    Scand J Immunol, 5 (8), 979-92
    DOI 10.1111/j.1365-3083.1976.tb03050.x, PubMed 996452

Publications 1975

  1. Dahl H, Degre M (1975)
    Separation of antiviral activity of human interferon from cell growth inhibitory effect
    Nature, 257 (5529), 799-800
    DOI 10.1038/257799a0, PubMed 1186865
  2. DEGRE M, ELGJO K (1975)
    INFLUENCE OF SYNTHETIC POLYNUCLEOTIDES AND INTERFERON ON INVITRO GROWTH OF CELLS DERIVED FROM A MOUSE SARCOMA
    ACTA PATH MICRO IM A, 1974 248, 61-68
  3. Djupesland G, Berdal P, Johannessen TA, Degré M, Stien R, Skrede S (1975)
    The role of viral infection in acute peripheral facial palsy
    Acta Otolaryngol, 79 (3-4), 221-7
    DOI 10.3109/00016487509124677, PubMed 1136761
  4. Elgjo K, Degré M (1975)
    Polyinosinic-polycytidylic acid: inhibition of cell proliferation in carcinogen-treated epidermis and in carcinogen-induced skin tumors in mice
    J Natl Cancer Inst, 54 (1), 219-21
    DOI 10.1093/jnci/54.1.219, PubMed 1113302
  5. Rollag H, Berdal BP, Bergan T, Degré M, Hovig B, Midtvedt T (1975)
    [Letter: Microstix and N-labstix "Ames"--unsafe for proving bacteriuria]
    Tidsskr Nor Laegeforen, 95 (3), 198
    PubMed 1118846
  6. Vandvik B, Degré M (1975)
    Measles virus antibodies in serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders, with special reference to measles antibody synthesis within the central nervous system
    J Neurol Sci, 24 (2), 201-19
    DOI 10.1016/0022-510x(75)90233-6, PubMed 1113135

Publications 1974

  1. Degré M (1974)
    [Virus as a cause of leukemia and blood cell disease in man]
    Tidsskr Nor Laegeforen, 94 (32), 2205-7
    PubMed 4140582
  2. Degré M (1974)
    Influence of exogenous interferon on the peripheral white blood cell count in mice
    Int J Cancer, 14 (6), 699-703
    DOI 10.1002/ijc.2910140602, PubMed 4463167
  3. DEGRE M, DAHL H (1974)
    INTERFERON-PRODUCTION AND PREVENTION OF VIRAL-INFECTIONS IN MICE BY COMPONENTS OF A MIXED BACTERIAL VACCINE
    ACTA PATH MICRO IM B, B 82 (6), 904-910
  4. Degré M, Dahl H (1974)
    Interferon production and prevention of viral infections in mice by components of a mixed bacterial vaccine
    Acta Pathol Microbiol Scand B Microbiol Immunol, 82 (6), 904-10
    DOI 10.1111/j.1699-0463.1974.tb02390.x, PubMed 4549161
  5. Degré M, Elgjo K (1974)
    Influence of synthetic polynucleotides and interferon on in vitro growth of cells derived from a mouse sarcoma
    Acta Pathol Microbiol Scand Suppl, Suppl 248, 61-8
    PubMed 4217556

Publications 1973

  1. Degré M (1973)
    [Acute effects of cigarette smoke on the respiratory tract]
    Tidsskr Nor Laegeforen, 93 (6), 362-5
    PubMed 4572673
  2. Degré M (1973)
    Influence of polyinosinic: polycytidylic acid on the circulating white blood cells in mice
    Proc Soc Exp Biol Med, 142 (4), 1087-91
    PubMed 4694806
  3. Degré M, Dahl H (1973)
    Enhanced effect of repeated administration of bacterial vaccine against viral respiratory infection
    Infect Immun, 7 (5), 771-6
    DOI 10.1128/IAI.7.5.771-776.1973, PubMed 4357990
  4. DEGRE M, MIDTVEDT T (1973)
    EFFECT OF STANDARD BACTERIAL VACCINE ON INFLUENZA-VIRUS INFECTION AND INTERFERON-PRODUCTION IN GERMFREE MICE
    ACTA PATH MICRO IM B, B 81 (6), 782-786
  5. Degré M, Midtvedt T (1973)
    Effect of standard bacterial vaccine on influenza virus infection and interferon production in germfree mice
    Acta Pathol Microbiol Scand B Microbiol Immunol, 81 (6), 782-6
    DOI 10.1111/j.1699-0463.1973.tb02277.x, PubMed 4521974
  6. Vandvik B, Froland SS, Hoyeraal HM, Stien R, Degré M (1973)
    Immunological features in a case of subacute sclerosing panencephalitis treated with transfer factor
    Scand J Immunol, 2 (4), 367-74
    DOI 10.1111/j.1365-3083.1973.tb02045.x, PubMed 4797728

Publications 1972

  1. Dahl H, Degré M (1972)
    A micro assay for mouse and human interferon
    Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (6), 863-70
    DOI 10.1111/j.0365-5563.1973.tb00012.x, PubMed 4345661
  2. Dahl H, Degré M (1972)
    Preventive effect of a nonviral interferon inducer, a bacterial vaccine, on experimental influenza in mice
    Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (3), 467-74
    DOI 10.1111/j.1699-0463.1972.tb00062.x, PubMed 4505773
  3. DAHL H, DEGRE M (1972)
    MICRO ASSAY FOR MOUSE AND HUMAN INTERFERON
    ACTA PATH MICRO IM B, B 80 (6), 863-870
  4. Degré M (1972)
    [Possible interaction between viral and bacterial agents in respiratory tract infections]
    Tidsskr Nor Laegeforen, 92 (8), 556-8
    PubMed 5021893
  5. Degre M (1972)
    [Slow virus infections]
    Tidsskr Nor Laegeforen, 92 (11), 783-5
    PubMed 5063782
  6. Degré M (1972)
    Effect of a standard bacterial vaccine on infection with an obligate intracellular parasite (Toxoplasma gondii) in mice
    Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (3), 478-80
    DOI 10.1111/j.1699-0463.1972.tb00064.x, PubMed 4505774
  7. Degré M, Vandvik B, Hovig T (1972)
    Subacute sclerosing panencephalitis: isolation and ultrastructural characterization of a measles-like virus from brain obtained at autopsy
    Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (5), 713-28
    DOI 10.1111/j.1699-0463.1972.tb00199.x, PubMed 4629361

Publications 1971

  1. Degré M (1971)
    Synergistic effect in viral-bacterial infection. 4. The leukocyte response to parainfluenza virus infection in the respiratory tract of mice, and the influence of antibiotics on the development of infection
    Acta Pathol Microbiol Scand B Microbiol Immunol, 79 (1), 88-94
    PubMed 4324936
  2. Degré M (1971)
    Synergistic effect in viral-bacterial infection. 5. Functional studies on the role of the ciliary activity in the mouse trachea
    Acta Pathol Microbiol Scand B Microbiol Immunol, 79 (2), 137-41
    PubMed 4325914
  3. Degre M, Dahl H (1971)
    Production of an interferon-like agent following inoculation with bacterial vaccine
    Proc Soc Exp Biol Med, 137 (1), 233-6
    DOI 10.3181/00379727-137-35551, PubMed 4325773
  4. Degré M, Elgjo K (1971)
    Methylcholanthrene-induced skin carcinogenesis modified by treatment with polyinosinic:polycytidylic acid (poly I:C)
    Acta Pathol Microbiol Scand A, 79 (6), 687-8
    PubMed 5123526
  5. Degré M, Midtvedt T (1971)
    Respiratory infection with parainfluenza 1, Sendai virus in gnotobiotic and conventional mice
    Acta Pathol Microbiol Scand B Microbiol Immunol, 79 (1), 123-4
    DOI 10.1111/j.1699-0463.1971.tb00042.x, PubMed 4324935
  6. Degré M, Solberg LA (1971)
    Synergistic effect in viral-bacterial infection. 3. Histopathological changes in the trachea of mice following viral and bacterial infection
    Acta Pathol Microbiol Scand B Microbiol Immunol, 79 (2), 129-36
    PubMed 4325913

Publications 1970

  1. Degré M (1970)
    [Quantitative and semiquantitative methods for the diagnosis of bacteriuria]
    Tidsskr Nor Laegeforen, 90 (1), 27-30
    PubMed 5426183
  2. Degré M (1970)
    Synergistic effect in viral-bacterial infection. 2. Influence of viral infection on the phagocytic ability of alveolar macrophages
    Acta Pathol Microbiol Scand B Microbiol Immunol, 78 (1), 41-50
    PubMed 4316170
  3. Skjorten F, Kierulf PB, Degré M (1970)
    Formation of hyaline microthrombi in the mouse. Evidence for dependence on the fibrinolytic system
    Acta Pathol Microbiol Scand A, 78 (3), 351-61
    PubMed 5507260

Publications 1969

  1. Degré M (1969)
    Phagocytic and bactericidal activities of peritoneal and alveolar macrophages from mice
    J Med Microbiol, 2 (3), 353-7
    DOI 10.1099/00222615-2-3-353, PubMed 5314333

Publications 1968

  1. Degré M (1968)
    [Etiological disgnosis of purulent meningitis]
    Tidsskr Nor Laegeforen, 88 (12), 1091-4
    PubMed 4387023
  2. Degré M, Glasgow LA (1968)
    Synergistic effect in viral-bacterial infection. I. Combined infection of the respiratory tract in mice with parainfluenza virus and Hemophilus influenza
    J Infect Dis, 118 (5), 449-62
    DOI 10.1093/infdis/118.5.449, PubMed 4302684

Publications 1967

  1. Degré M (1967)
    Reproducibility of staphylococcal bacteriophage types by use of different concentrations of bacteriophage
    Appl Microbiol, 15 (4), 907-11
    PubMed 4227800

Publications 1966

  1. Degré M (1966)
    Simple quantitative methods in the bacteriological diagnosis of urinary tract infection
    J Oslo City Hosp, 16 (8), 184-96
    PubMed 5329982
  2. Degré M (1966)
    Bacteriophage typing of Staphylococcus aureus using a single concentration of phage (100 x RTD)
    Acta Pathol Microbiol Scand, 66 (1), 105-12
    DOI 10.1111/apm.1966.66.1.105, PubMed 4224085

Publications 1965

  1. Degrè M, Ulstrup JC (1965)
    [Bacteriological studies on otitis media. 1-year case material]
    Tidsskr Nor Laegeforen, 85 (12), 994-7
    PubMed 5864803
  2. Daae L, Degré M (1965)
    [Bacteriological studies of urine. A comparison between washed down specimens and catheterized specimens from bedridden women]
    Tidsskr Nor Laegeforen, 85 (12), 1003-5
    PubMed 5865811

Publications 1964

  1. DEGRE M (1964)
    [DISINFECTION OF THE DUMMY FIGURES USED IN TRAINING FOR MOUTH-TO-MOUTH RESPIRATION METHODS]
    Tidsskr Nor Laegeforen, 84, 1112-4
    PubMed 14230470

Publications 1962

  1. DEGRE M (1962)
    [Anaphylactic reaction to carisoprodol]
    Tidsskr Nor Laegeforen, 82, 1589
    PubMed 14026463

Publications 1957

  1. TIGYI A, LISSAK K, DEGRE M, PETER K (1957)
    [Role of neurohormonal factors in pathological changes in lungs]
    Magy Tud, 8 (1-2), 86-9
    PubMed 13450585
 
Page visits: 1978